# Flotek Industries Inc: Form 10-Q for the period ended Mar 31, 2021

- Company: [Flotek Industries Inc](/companies/ftk.md) (CIK 928054)
- Form: 10-Q
- Filed: 2021-05-10
- Accepted by EDGAR: May 10, 2021, 16:10 ET
- Period: 2021-03-31
- Accession: 0000928054-21-000085
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/928054/000092805421000085/ftk-20210331.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/928054/000092805421000085/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2021-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2021-01-01 to 2021-03-31 | $11.8m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Research and development | 3 months, 2021-01-01 to 2021-03-31 | $1.5m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2021-01-01 to 2021-03-31 | $4.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2021-01-01 to 2021-03-31 | −$8.2m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2021-01-01 to 2021-03-31 | $18.0k | us-gaap:InterestExpense |
| Income tax | 3 months, 2021-01-01 to 2021-03-31 | $6.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2021-01-01 to 2021-03-31 | −$8.3m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2021-01-01 to 2021-03-31 | −$0.12 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2021-01-01 to 2021-03-31 | −$0.12 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2021-01-01 to 2021-03-31 | 68,447,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2021-01-01 to 2021-03-31 | −$5.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2021-01-01 to 2021-03-31 | $19.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2021-03-31 | $33.9m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2021-03-31 | $59.9m | us-gaap:AssetsCurrent |
| Total assets | at 2021-03-31 | $78.7m | us-gaap:Assets |
| Current liabilities | at 2021-03-31 | $30.2m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2021-03-31 | $39.1m | us-gaap:Liabilities |
| Long-term debt | at 2021-03-31 | $642.0k | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2021-03-31 | $5.0m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2021-03-31 | $39.6m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 35,704 characters.

### Executive Summary

This Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) should be read in conjunction with the unaudited condensed consolidated financial statements and the related notes thereto of this Quarterly Report, as well as the Annual Report. Phrases such as “Company,” “we,” “our,” and “us” refer to Flotek Industries, Inc. and its subsidiaries.

Flotek Industries, Inc. is a technology-driven chemistry and data company that serves customers in industrial, commercial and consumer markets. The Company serves specialty chemistry needs that span from downstream, midstream and upstream, both domestic and international, energy markets to applications of U.S. manufactured, sanitizers, surface cleaners and disinfectants for industrial, commercial and consumer use.

The Company’s CT segment develops, manufactures, packages, distributes, delivers, and markets specialty chemicals that enhance the profitability of hydrocarbon producers and cleans surfaces in both commercial and personal settings to help reduce the spread of bacteria, viruses and germs.

The Company’s DA segment enables users to maximize the value of their hydrocarbon associated processes by providing analytics associated with the streams in seconds rather than minutes or days. The real-time access to information prevents waste, reduces reprocessing, and allows users to pursue automation of their hydrocarbon streams to maximize their profitability.

During the second quarter of 2020, the Company acquired 100% ownership of JP3 in a cash-and-stock transaction. JP3’s real-time data platforms combine the energy industry’s only field-deployable, inline optical analyzer with proprietary cloud visualization and analytics, targeting an increase of processing efficiencies and valuation of natural gas, crude oil and refined fuels. In conjunction with the acquisition of JP3, the Company created the DA segment.

The Company was impacted as a result of the outbreak of COVID-19 that spread throughout the U.S. and the world during 2020, with effects continuing into 2021. For a discussion of the impacts of COVID-19, see “COVID-19 Effects and Actions” and “Outlook” in this Item 2 of this Quarterly Report.

### Company Overview

The Company has two operating segments, CT and DA, which are both supported by the Company’s continuing Research & Innovation (“R&I”) advanced laboratory capabilities.

### Chemistry Technologies

The Company’s CT segment includes an energy-focused product line that is comprised of proprietary green chemistries, specialty chemistries, logistics and technology services. The Company designs, develops, manufactures, packages, distributes, delivers and markets reservoir-centric fluid systems, including specialty and conventional chemistries, for use in oil and gas well drilling, cementing, completion, remediation and stimulation activities designed to maximize recovery in both new and mature fields, as well as to reduce health and environmental risk by using greener chemicals. Customers of this product line of the CT segment include major integrated oil and gas companies, oilfield services companies, independent oil and gas companies, national and state-owned oil companies and international supply chain management companies.

In 2020, the Company leveraged historical expertise, existing infrastructure, personnel, supply chain, research and resident consumer market experience to address the emerging demand for sanitizers, surface cleaners and disinfectants for both commercial and personal use. Rather than operating under relaxed pandemic-related guidelines, the Company sought to produce FDA and EPA compliant products by completing all necessary upgrades to its already ISO 9001:2015 certified facility in Marlow, Oklahoma. Today, the Company has a portfolio of specialty green chemical products designed to address the long-term challenges created by the current COVID-19 pandemic and in preparation for future outbreaks. Additionally, the Company’s technology helps customers reduce their carbon footprint and reduce energy consumption and emissions by minimizing processing and waste. The Company has made a commitment of being in this market for the long-term.

### Data Analytics

The Company’s DA segment, created in conjunction with the acquisition of JP3 in May 2020, includes the design, development, production, sale and support of equipment and services that create and provide valuable real time information about the composition and properties for customers' oil, natural gas and refined products. The DA segment is continuing its transition to a recurring revenue subscription model of selling its line of Verax analyzers, deployed in the field across the oil and gas sector, support contracts and software services via its cloud-based Viper software platform, as well as selling hardware-related solutions during the transition to a recurring revenue model.

The customers of the DA segment diversify the revenues of the Company and span across the entire oil and gas market, including upstream, midstream, refineries and distribution networks. The segment helps its customers generate additional profit by enhancing blending, optimizing the natural mixing between adjacent batches of different fuels (“transmix”), ensuring product quality while enabling automation of fluid handling. To date, the segment has focused sales solely on North American markets; however, the segment began preparing for international deployments, including export control investigations, certifications and product design modifications to meet the demands of overseas installations. In 2020, the Company hired a business development executive, who is developing sales opportunities in the international market.

### Research & Innovation

R&I supports both segments through green chemistry formulation, specialty chemical formulations, FDA and EPA regulatory guidance, technical support, basin and reservoir studies, data analytics and new technology projects. The purpose of R&I is to supply the Company’s segments with enhanced products and services that generate current and future revenues, while advising Company management on opportunities concerning technology, environmental and industry trends. The R&I facilities support advances in chemistry performance, detection, optimization and manufacturing.

### COVID-19 Effects and Actions

In March 2020, the World Health Organization declared the outbreak of COVID-19 a global pandemic that spread throughout the U.S. and the world. In late 2020, major pharmaceutical companies developed vaccines and received approval for wide-scale distribution in the U.S. and other countries. The vaccination effort is proceeding in the U.S. and the world. However, variant strains of the virus have emerged, which create additional uncertainty on the extent and the duration of the pandemic.

The pandemic negatively impacted the U.S. and global economy, disrupted global supply chains and the domestic and international oil and gas markets, and increased volatility in financial markets in 2020. These effects materially and adversely affected, and may continue to materially and adversely affect, the demand for oil and natural gas as well as for the Company’s services and products.

The Company’s CT segment is energy-focused with product lines comprised of specialty chemistries, logistics and technology services. Customers of the CT segment include major integrated oil and gas companies, oilfield services companies, independent exploration and production companies, national and state-owned oil companies, and international supply chain management companies. Due to customer activity levels in this industry, the Company experienced materially reduced revenues and cash flows during 2020, which continued for the first quarter of 2021.

Outside the oil and gas sector, the COVID-19 pandemic increased demand for certain specialty chemicals, particularly sanitizers, surface cleaners and disinfectants. In 2020, the Company launched a diversified line of FDA and EPA-compliant sanitizers, surface cleaners and disinfectants for industrial, commercial and consumer use. These products build on the Company’s historical expertise in chemistry and leverage its infrastructure, personnel, competencies, supply chain, research and historic consumer market experience. The continued impact of COVID-19 and subsequent modification of social behavior in regard to the heightened attention to hygiene and sanitation provide a sustainable yet challenging market to expand the Company’s portfolio.

The DA segment’s largest customer base, the oil and gas midstream market, reduced gathering and infrastructure capital spending in 2020. In addition, the pandemic impacted the DA segment due to reduced access to facilities to complete new installations for a portion of the year. As a result, spending for the DA segment’s products and services has also been impacted by lower consumer demand. As a result, sales and cash flows were below target for the DA segment.

The Company expects the current economic situation to negatively impact the energy sector for an extended period of time, with oil demand recovering during 2021 but not returning to the pre-COVID-19 level. Any further material COVID-19 disruption or significant setback in oil and gas demand arising from a slower economic recovery could negatively impact the Company and could result in additional impairments in the future. Future developments of the COVID-19 crisis are uncertain and related implications could materially and adversely affect the Company’s business, operations, operating results, financial condition, liquidity and/or capital levels.

While the full impact of the COVID-19 pandemic continues to evolve and the full extent of the impact is not yet known, the Company continues to closely monitor the effects of the pandemic on commodity demands, and on its customers, operations and employees. Any future developments and effects are highly uncertain and cannot be predicted, including:

- the scope and duration of the pandemic;
- effectiveness of vaccines;
- emergence of new coronavirus variants;
- further adverse revenue and net income effects; impairments;
- disruptions to the Company’s operations;
- third-party providers’ ability to support the Company’s operations;
- limitations on domestic and international travel for sales, system installations, and support;
- customer shutdowns of oil and gas exploration and production;
- the effectiveness of work from home arrangements;
- modifications to work schedules, including manufacturing shifts;
- impacts on employees from illness, school closures and other community response measures;
- any actions taken by governmental authorities and other third parties in response to the pandemic; and
- temporary closures of the Company’s facilities or the facilities of its customers and suppliers.

The pandemic caused the Company to alter its business working practices, including work schedules, manufacturing shifts, employee travel, work locations, meetings and participation in events and conferences. In addition, the Company and most of its customers continued the practice of social distancing and work-from-home procedures, which have had, and may continue to have, an impact on the ability of employees and management of the Company to communicate and work efficiently. These practices are gradually changing with increased vaccination levels in the U.S. and the world. There is no certainty that these actions will mitigate risks posed by the virus to the Company’s workforce.

In response to market conditions and anticipating ongoing volatility, the Company reduced its cost structure in 2020 to meet anticipated market activity and reduce the Company’s break-even level. In the second half of 2020 the Company recorded additional impairment charges of goodwill and intangible assets as well as an increase to the provision of excess and obsolete inventory.

### Outlook

The COVID-19 pandemic negatively impacted the U.S. and global economy, disrupted global supply chains and the domestic and international oil and gas markets, and increased volatility in financial markets. While market prices for West Texas Intermediate and Brent crude oil rebounded from lows during the initial months of the pandemic in 2020 to exceed $50 per barrel during the first quarter of 2021, many major integrated oil and gas companies and independent oil and gas companies have kept their 2021 budgets generally unchanged, though such budgets may change if crude oil prices increase. Uncertainty exists about the extent and the duration of the resulting industry contraction and consolidation. In addition, the oilfield services industry remains over supplied and the timing of returns to pre-pandemic pricing levels remains uncertain. While uncertainty remains around the extent and duration of the pandemic, there are positive indicators that the U.S. economy is recovering, including improvements in oil and gas demand, rising COVID-19 vaccination levels, and resumption of travel and business activities.

Climate change continues to be a focus for the Company as investors are increasingly scrutinizing companies linked to the oil and gas industry through environmental, social and corporate governance (“ESG”) factors to promote clean energy and sustainability. In addition, the impact of the actions of the new presidential administration and Congress on the economy and financial markets is uncertain in the current year and longer term. During his first months in office, the President signed many executive orders, including ones with implications for stakeholders in the energy industry, such as canceling the Keystone XL Pipeline and another for the U.S. to rejoin the Paris Agreement on climate change. The U.S. Department of Interior (“DOI”) issued an order in January, placing a 60-day freeze on agency permit approvals and pausing federal oil and gas leasing for a review of all existing leasing and permitting practices related to fossil fuel development on public lands and waters. In March 2021, the DOI allowed the suspension to expire. In addition, the President announced proposed plans to raise the corporate tax rate to help finance his proposed infrastructure plan. These and other potential actions by the new administration could have negative and/or positive impacts on the Company’s business and customers.

Amid the current environment with increased business commitments related to ESG, the Company’s products and services offer a significant benefit to businesses seeking to improve their ESG performance, including improving the safety, reliability and efficiency of their operations. The Company offers sustainable chemistry solutions, tailoring product selection to enable operational efficiencies, improve water management and reduce greenhouse gas emissions for its customers in the exploration and production sector of the oil and gas industry. Further, our patented line of Complex nano-Fluid® (also known as CnF®)

chemistry technologies, are formulated with highly effective, plant-based solvents offering safer, sustainable alternatives to toxic BTEX-based (benzene, toluene, ethylbenzene and xylene) chemicals. Additionally, the Company’s real-time sensor technology helps to enable process and operational efficiencies, minimize waste and processing and reduce emissions.

The Company believes that an increase in the adoption of green specialty chemicals could benefit our business and reduce the impact of the current decrease in drilling and completions activity. The key sales focus of the Company is growing market share by improving returns for current customers, rebuilding relationships with past customers and identifying new customers that could benefit from chemistry solutions. Additionally, the Company is focused on total cost of recovery per barrel of oil equivalent, rather than initial cost, as well as strengthening the publicly available evidence for the efficacy of using advanced CnF® products to materially impact oil and gas recovery and profitability for operators.

The sanitizers, surface cleaners and disinfectants industry is expanding, associated with the continued impact of the COVID-19 pandemic and the need for individuals, businesses, schools and governments to minimize the spread of the coronavirus. Industry growth is also anticipated due to the modification of social behaviors in regard to the heightened attention to hygiene and sanitation. In 2020, the Company launched a diversified line of FDA-compliant sanitizers, surface cleaners and disinfectants for industrial, commercial and consumer use. The Company believes this market provides an opportunity to expand the Company’s portfolio of chemistry products to meet the growing demand.

The use of data and analytics is a growing trend in all industries where technology is used to analyze large datasets of operational information to improve performance, as well as predictive maintenance, advanced safety measures and reduced environmental impact of operations. The Company believes that data and analytics is an area for growth. Hence, in 2020, the Company acquired JP3 and formed the DA segment. To date, the segment has focused sales solely on North American markets; however, the segment began preparing for international deployments, including export control investigations, certifications and product design modifications to meet the demands of overseas installations. The Company hired a business development executive, who is developing sales opportunities in the international market.

The Company continues to develop technologies to ensure our ability to provide differentiated products and services to our customers. Partnering closely with our clients to create and implement specialty chemical products and compositional analyzers remains a focus for the organization. Differentiated products and services are the result of the deployment of the organization’s capabilities and expertise in alignment with customer success. The continuing search for new ways to help make customers successful positions the Company as a leader in advanced chemicals and technology.

The Company’s emphasis in 2021 is executing the plan established by the executive team to recover from the varied impacts of COVID-19 and grow the Company’s businesses. The CT segment is focused on marketing our products and services to new and existing customers, while expanding the sanitizers, surface cleaners and disinfectants product line. The DA segment will maintain its domestic sales effort while pursuing international growth. The Company does not anticipate a material escalation in our maintenance capital spending year-over-year. In 2021, the Company is enhancing its focus on ESG and the responsible management of products and services through our Quality Assurance and Quality Control Program and Chemical Spill Prevention Program, adhering to ISO 9001:2015 standards.

### Consolidated Results of Operations (in thousands):

### Consolidated Results of Operations: Three Months Ended March 31, 2021, Compared to the Three Months Ended March 31, 2020

|  | Three months ended March 31, 2021 | 2020 | $ Change | % Change |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $11,770 | $19,416 | $(7,646) | (39.4)% |
| Operating expenses (excluding depreciation and amortization) | 13,801 | 22,841 | (9,040) | (39.6)% |
| Operating expenses % | 117.3% | 117.6% |  |  |
| Corporate general and administrative costs | 4,361 | 4,493 | (132) | (2.9)% |
| Corporate general and administrative % | 37.1% | 23.1% |  |  |
| Depreciation and amortization | 307 | 2,191 | (1,884) | (86.0)% |
| Research and development | 1,542 | 2,555 | (1,013) | (39.6)% |
| Loss (gain) on disposal of long-lived assets | 2 | (33) | 35 | (106.1)% |
| Impairment of fixed assets and long-lived assets | — | 57,454 | (57,454) | (100.0)% |
| Loss from operations | (8,243) | (70,085) | (61,842) | 88.2% |
| Operating margin % | (70.0)% | (361.0)% |  |  |
| Interest and other income (expense), net | (51) | (51) | — | —% |
| Loss before income taxes | (8,294) | (70,136) | (61,842) | 88.2% |
| Income tax (expense) benefit | (6) | 6,169 | (6,175) | (100.1)% |
| Net loss | $(8,300) | $(63,967) | $(55,667) | 87.0% |

Consolidated revenue for the three months ended March 31, 2021, decreased $7.6 million, or 39.4%, versus the same period of 2020. The decrease in revenue during the first quarter of 2021 compared to the first quarter of 2020 was driven by impacts from both the supply and the demand side, primarily in our CT segment. The COVID-19 pandemic negatively impacted economic activity and reduced global demand for oil and gas, a key sector for our customer base. The Company’s domestic and international revenue for the first quarter of 2021 decreased as demand from major customers and smaller operators has not returned to the pre-pandemic levels of first quarter 2020. Partially offsetting the decrease, the first quarter of 2021 includes $1.5 million of revenue for the Data Analytics segment, which was created in May 2020 upon acquiring JP3.

Consolidated operating expenses (excluding depreciation and amortization) for the three months ended March 31, 2021, decreased $9.0 million, or 39.6%, versus the same period of 2020, and as a percentage of revenue, remained flat. The decrease in operating expenses resulted from reduced cost of sales due to lower sales activity during the first quarter of 2021 compared to the first quarter of 2020 associated with COVID-19 impacts and related declines in activity. The Company’s operating expenses in the first quarter of 2021 also benefited from actions taken in 2020 that reduced the Company’s facility footprint and tank rentals, lowered personnel costs and cut costs within the supply chain. These reduced costs were partially offset by new operating expenses for the DA segment that was acquired in the second quarter of 2020 as well as the introduction of our sanitizer, surface cleaner and disinfectant products in the second quarter of 2020.

Corporate general and administrative (“CG&A”) expenses are not directly attributable to products sold or services provided. CG&A costs for the three months ended March 31, 2021, decreased $0.1 million, or 2.9%, versus the same period of 2020. As a percentage of revenue, CG&A increased 14.0% for the three months ended March 31, 2021, as revenue declined in the first quarter of 2021 as compared to the same period of 2020. The decrease in CG&A costs was primarily due to lower personnel costs in the first quarter of 2021 related to the reduction in force costs accrued in the first quarter of 2020 for $0.5 million combined with first quarter 2021 CG&A personnel costs that were $0.4 million lower. Occupancy expense also decreased $0.2 million due to the Company moving out of its corporate headquarters office and consolidating into the Global Research and Innovation Center. Offsetting the decreases was an increase in professional fees of $0.9 million that included increased accounting consultant and contractor costs of $0.6 million and increased audit fees of $0.4 million.

Depreciation and amortization expense decreased $1.9 million, or 86.0% for the three months ended March 31, 2021, versus the same period of 2020, primarily due to impairments of fixed and long-lived assets recorded in the first quarter of 2020.

Research and development costs decreased $1.0 million, or 39.6% for the three months ended March 31, 2021, versus the same period of 2020 due to lower personnel costs as a result of our reduction in workforce accrued in the first quarter 2020.

Impairment of fixed and long-lived assets decreased due to the first quarter 2020 write-down of $54.7 million in the CT segment and a corporate-level write-down of $2.8 million. See Note 8, “Impairment of Fixed and Long-lived Assets, in Item 1, Financial Statements, of this Quarterly Report.” No impairments of fixed and long-lived assets occurred in the first quarter of 2021.

Loss from operations decreased $61.8 million, or 88.2%, for the three months ended March 31, 2021, versus the same period in 2020. Loss from operations decreased primarily as a result of the $57.5 impairment of fixed and long-lived assets in the first quarter of 2020 and no impairments in the same quarter of 2021.

The Company’s income tax expense for the first quarter of 2021 was minimal. The Company recorded an income tax benefit of $6.2 million for the first quarter of 2020, primarily as a result of the extended net operating loss carryback provisions included in the CARES Act initially recorded in the first quarter 2020.

### Results by Segment (in thousands):

### Chemistry Technologies Results of Operations: Three Months Ended March 31, 2021, Compared to the Three Months Ended March 31, 2020

|  | Three months ended March 31, 2021 | 2020 |
| --- | ---: | ---: |
| Revenue | $10,302 | $19,416 |
| Loss from operations | (3,589) | (70,269) |

CT revenue for the three months ended March 31, 2021, decreased $9.1 million versus the same period of 2020. The decrease in revenue during the first quarter of 2021 compared to the first quarter of 2020 was driven by impacts from both the supply and the demand side. The COVID-19 pandemic negatively impacted economic activity and reduced global demand for oil and gas, a key sector of our customer base. The Company’s domestic and international revenue for the first quarter of 2021 decreased as demand from major customers and smaller operators has not returned to the pre-pandemic levels of first quarter 2020. In addition, the CT segment granted price concessions due to the economic environment.

Loss from operations for the CT segment for the three months ended March 31, 2021, decreased $66.7 million, or 94.9%, versus the same period of 2020. The decrease in loss from operations is due to lower revenue and significantly lower expenses, primarily the result of no impairments in the first quarter of 2021 versus impairment charges of fixed and long-lived assets of $54.7 million in the same period of 2020. Other decreases in expenses occurred due to the first quarter of 2020 including a $2.3 million terpene purchase commitment loss with no comparable activity in 2021. Personnel costs declined period over period by $1.8 million, which included first quarter 2020 severance costs of $0.6 million for reduction in force actions. Office costs and equipment and facilities costs decreased a combined $0.6 million period over period from the consolidation of the Company’s physical facilities.

### Data Analytics Results of Operations: Three Months ended March 31, 2021

|  | Three months ended March 31, 2021 |
| --- | ---: |
| Revenue | $1,468 |
| Loss from operations | (292) |

On May 18, 2020, the Company purchased JP3 and formed the DA segment. Segment revenue for the first quarter of 2021 was $1.5 million, an increase of $0.2 million over fourth quarter 2020 revenue of $1.3 million, driven primarily by increased equipment sales.

### Critical Accounting Policies and Estimates

The Company’s financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America. Preparation of these statements requires management to make judgments, estimates, and assumptions that affect the amounts reported in the financial statements and accompanying footnotes. Part II, Item 8 — Financial Statements and Supplementary Data, Note 2 of “Notes to Consolidated Financial Statements” and Part II, Item 7 — Management’s Discussion and Analysis of Financial Condition and Results of Operations, “Critical Accounting Policies and Estimates” of the Company’s Annual Report, and the “Notes to Unaudited Condensed Consolidated Financial Statements” of this Quarterly Report describe the significant accounting policies and critical accounting estimates used to prepare the consolidated financial statements. Critical accounting policies and estimates are defined as those that are both most important to the portrayal of the Company’s financial condition and results of operations and require management’s most subjective judgments. The Company regularly reviews and challenges judgments, assumptions and estimates related to critical accounting policies, including goodwill and other intangible assets. There have been no significant changes in the Company’s critical accounting policies and estimates during the three months ended March 31, 2021.

### Recent Accounting Pronouncements

Recent accounting pronouncements which may impact the Company are described in Note 2, “Recent Accounting Pronouncements,” in Part I, Item 1 — “Financial Statements” of this Quarterly Report.

### Capital Resources and Liquidity

### Overview

The Company’s ongoing capital requirements relate to the need to acquire and maintain equipment and fund working capital requirements. During the first three months of 2021, the Company funded capital requirements primarily with cash on hand.

As of March 31, 2021, the Company had available cash and cash equivalents of $33.9 million, as compared to $38.7 million at December 31, 2020. The Company recorded an operating loss in the first quarter of 2021, and recorded $5.3 million of net cash used for operating activities and $0.1 million of net cash used for financing activities. Cash used in investing activities was minimal..

### Liquidity

The effects of the COVID-19 pandemic and the volatility in oil prices during 2020 and first quarter of 2021 materially and adversely affected, and may continue to materially and adversely affect, the demand for oil and natural gas as well as for our services and products. While the full impact and duration of the COVID-19 outbreak is not yet known, we are closely monitoring the effects of the pandemic on commodity demands and on our customers, as well as on our operations and employees. See “COVID-19 Effects and Actions” for developments and possible effects.

The Company currently funds its operations and growth primarily from cash on hand. The ability of the Company to grow and be competitive in the marketplace is dependent on the availability of adequate capital. Access to capital is dependent, in large part, on the Company’s cash flows and the availability of and access to debt and equity financing. The Company has a history of losses and negative cash flows from operations and expects to utilize a significant amount of cash in operations in the following year. While we believe that our cash and liquid assets will provide us with sufficient financial resources to fund operations and meet its capital requirements and anticipated obligations as they become due, a prolonged COVID-19 impact, a slower than expected recovery of oil and gas markets, or reduced spending at our customers could have a negative impact on our liquidity.

Accordingly, while the Company believes that its existing cash will enable it to fund its operations and growth, the Company cannot guarantee the level of cash flows in the future. In the event that the Company’s existing cash on hand is not sufficient to fund operations, meet our capital requirements or satisfy the anticipated obligations as they become due, the Company expects to take further action to protect its liquidity position. Such actions may include, but are not limited to:

- Sale of non-core real estate properties;
- Sale-leaseback transactions of facilities;
- Sale of excess inventory and/or raw materials;
- Entry into a borrowing facility with one or more lenders;
- Reducing executive salaries and/or board of directors’ fees, or making a portion of those fees or salaries in equity instead of cash; and
- Reducing professional advisory fees and headcount;
- Raising equity either in the public markets or via a private placement offering.

However, with respect to anticipated transactions, there can be no assurance that such matters can be implemented on acceptable terms. For a further discussion of the risks surrounding the Company’s access to capital, please see Item 1A, “Risk Factors” in the Company’s Annual Report.

The Company expects capital spending to be less than $1.0 million in 2021.

### Cash Flows

Consolidated cash flows by type of activity are noted below (in thousands):

|  | Three months ended March 31, 2021 | 2020 |
| --- | ---: | ---: |
| Net cash used in operating activities | $(5,265) | $(23,777) |
| Net cash (used in) provided by investing activities | (17) | 3,322 |
| Net cash (used in) provided by financing activities | (81) | 253 |
| Effect of changes in exchange rates on cash and cash equivalents | 23 | (109) |
| Net change in cash, cash equivalents and restricted cash | $(5,340) | $(20,311) |

#### Operating Activities

Net cash used in operating activities was $5.3 million and $23.8 million during the three months ended March 31, 2021 and 2020, respectively. Consolidated net loss for the three months ended March 31, 2021 and 2020, totaled $8.3 million and $64.0 million, respectively.

During the three months ended March 31, 2021, non-cash adjustments to net income totaled $1.2 million as compared to $61.3 million for the same period of 2020.

- For the first quarter of 2021, non-cash charges included $0.3 million for depreciation, which was lower than the first quarter of 2020 due to asset impairments taken in 2020, and a $0.3 million decrease in the fair value of contingent consideration.
- For the three months ended March 31, 2020, contributory non-cash adjustments consisted primarily of $57.5 million of impairment charges, which included a $30.2 million impairment of fixed assets, $19.9 million impairment of intangible assets and $7.4 million of impairment of right-of-use assets. In addition, non-cash charges included $2.2 million for depreciation and amortization.

During the three months ended March 31, 2021, changes in working capital provided $1.9 million of cash as compared to using $21.1 million for the same period of 2020.

- For the first quarter of 2021, the cash provided by working capital primarily resulted from routine operations, including a reduction in accounts receivable and other current assets totaling $0.5 million combined with an increase of accounts payable of $0.7 million, partially offset by a decrease in accrued liabilities of $0.3million.
- For the three months ended March 31, 2020, the use of cash in working capital primarily resulted from a reduction in accrued liabilities and accounts payable of $25.1 million, which included two one-time payments made: one payment of $15.8 million to amend a long-term supply agreement and one to pay $4.1 million for the final post-closing working capital adjustment related to the 2019 sale of the Company’s Consumer and Industrial Chemistry Technologies segment. Decreases in accounts receivable, inventories and other current assets provided cash of $10.1 million.

#### Investing Activities

Net cash used in investing activities for the three months ended March 31, 2021 was not material. Net cash provided by investing activities was $3.3 million for the three months ended March 31, 2020. Cash provided by investing activities included $3.3 million from sale of the Florida Chemical Company in 2019 and the subsequent release of escrow amounts.

#### Financing Activities

Net cash used in financing activities was $0.1 million for the three months ended March 31, 2021, primarily for purchases of common stock related to tax withholding requirements. Net cash provided by financing activities was $0.3 million for the three months ended March 31, 2020, primarily from the sale of common stock.

## Market risk

As filed, 347 characters.

The Company is exposed to market risk from changes in interest rates, commodity prices and foreign currency exchange rates. There have been no material changes to the quantitative or qualitative disclosures about market risk set forth in Part II, Item 7A “Quantitative and Qualitative Disclosures About Market Risk” of the Company’s Annual Report.

## Controls and procedures

As filed, 4,903 characters.

### Evaluation of Disclosure Controls and Procedures

The Company’s disclosure controls and procedures are designed to ensure that information required to be disclosed by the Company in reports filed or submitted under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. The Company’s disclosure controls and procedures are also designed to ensure such information is accumulated and communicated to management, including the principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosures. There are inherent limitations to the effectiveness of any system of disclosure controls and procedures, including the possibility of human error and the circumvention or overriding of controls and procedures. Accordingly, even effective disclosure controls and procedures can only provide reasonable assurance that control objectives are attained.

The Company identified deficiencies in its internal control over financial reporting that represented material weaknesses as of December 31, 2020. Specifically, the Company’s management determined that the Company did not, as of December 31, 2020, design and maintain effective internal controls over financial reporting. The material weaknesses relate to: (1) ineffective design and operation of controls over nonrecurring transactions, including recognition of items and cash flow presentation relating to disposal transactions, and operating ineffectiveness of controls relating to impairment evaluations; (2) ineffective design and operating effectiveness over forecasts used in business combinations and impairment evaluations; and (3) the ineffective design and operating effectiveness of the assessment of going concern.

The Company believes that, notwithstanding the material weaknesses mentioned above, the consolidated financial statements contained in this Quarterly Report present fairly, in all material respects, the consolidated financial positions, results of operations and cash flows of the Company and its subsidiaries in conformity with generally accepted accounting principles in the United States as of the dates and for the periods stated therein.

The Company’s management, including its principal executive officer and principal financial officer, have evaluated the effectiveness of the Company’s disclosure controls and procedures, as defined by Rule 13a-15(e) and 15d-15(e) of the Exchange Act as of March 31, 2021, and has concluded that the Company’s disclosure controls and procedures were not effective as of March 31, 2021, due to the material weaknesses in internal control over financial reporting described above.

### Remediation Plan and Status

The Company has implemented and continues to implement certain remediation actions and continues to test and evaluate the elements of the remediation plan. These elements include:

- Implementing monitoring controls over the review and validation of both tangible and intangible assets;
- Expanding controls over impairments of goodwill and long-lived assets;
- Enhancing specificity in the design and implementation of controls around nonrecurring, complex accounting activities, with the assistance of technical subject-matter experts;
- Implementing controls for forecasting and budgeting, to include additional process documentation and precision;
- Expanding monthly management review controls; and,
- Enhancing existing control procedures around the quarterly going concern analysis process.

The Company believes that the actions listed above will provide appropriate remediation of the material weaknesses; however, the testing of the effectiveness of the controls has not been completed by the Company. Due to the nature of the remediation process and the need for sufficient time after implementation to evaluate and test the effectiveness of the controls, no assurance can be given as to the timing for completion of remediation. The material weaknesses will be fully remediated when the Company concludes that the controls have been operating for sufficient time and independently validated by management. Further, in 2021 the Company made a strategic decision to bring internal audit in-house and hired a director of internal audit to manage internal controls and the remediation process.

### Changes in Internal Control Over Financial Reporting

Except for the items described above, there have been no changes in the Company’s system of internal control over financial reporting (identified in connection with the evaluation required by Rule 13a-15(d) and Rule 15d-15(d) under the Exchange Act) during the three months ended March 31, 2021, that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

Filed May 10, 2021.
Source: SEC EDGAR, the filing index for accession 0000928054-21-000085. Last ingested by Listed: Nov 14, 2026, 17:51 ET. No prices; not investment advice.
